Research Progress on Resistance Mechanisms of Epidermal Growth Factor Receptor 
Tyrosine Kinase Inhibitors in Non-small Cell Lung Cancer

Research Progress on Resistance Mechanisms of Epidermal Growth Factor Receptor 
Tyrosine Kinase Inhibitors in Non-small Cell Lung Cancer

With a greater understanding of tumor biology, novel molecular-targeted strategies that block cancer progression pathways have been evaluated as a new therapeutic approach for treating non-small cell lung cancer (NSCLC). Epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs), such a...

Full description

Bibliographic Details
Main Authors: Yuan LI, Lihua SONG
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2012-02-01
Series:Chinese Journal of Lung Cancer
Subjects:
Epidermal growth factor receptor-tyrosine kinase inhibitors
Lung neoplasms
Drug resistance
Mechanism
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2012.02.08

Internet

http://dx.doi.org/10.3779/j.issn.1009-3419.2012.02.08

Similar Items